Abstract
Introduction: Every year in Italy FLU causes 5 millions of infected. This
causes several productivity losses and costs for hospitalizations and GP
visits. Our aim is to quantify the amount of social savings due to the
implementation of a FLU vaccination strategy for people aged 50-64 in Italy
in order to determine the optimal budget allocation.
Methods: The dynamic model InfluSim version 2.0 was used. Then we
evaluated the social savings due to the implementation of different strategies
for FLU prevention using published data on oseltamvir, zanamvir and vaccine
costs and effectiveness. A sensitivity analysis was performed varying the
Basic Reproduction Number from 1.68 to 3, consistently with major literature
indications and assuming resource consumption to be distributed as a Gamma
and Inv Log Normal function. We then performed a budget impact analysis
using the Weinstein model.
Results: Results showed that the implementation of a vaccination policy in
favour of the entire 50-64 year old population brings forth a social saving
of 12-15% if compared with the current vaccination policy. Budget impact
analysis showed that up to 30% utilization of the vaccine, every share of
population coverage is the dominant strategy compared to the use of antivirals.
Conclusions: This study is a first example of how to integrate an epidemiological
dynamic model with a budget impact analysis. Decision makers are expected
to use this type of approach to support their healthcare strategies.
Titolo tradotto del contributo | [Autom. eng. transl.] Economic analysis for the extension of influenza vaccination to individuals aged 50-64: social savings and Budget Impact analysis |
---|---|
Lingua originale | Italian |
pagine (da-a) | 137-150 |
Numero di pagine | 14 |
Rivista | PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES |
Volume | 10 |
Stato di pubblicazione | Pubblicato - 2008 |
Keywords
- costo beneficio
- perdite produttività